Singapore Medical Group Limited operates medical clinics and provides general medical services in Singapore. The company operates through three segments: Health Business, Diagnostic & Aesthetics Business, and Others. The Health Business segment offers obstetrical and gynaecological services for the wellness of women; oncology services, including the prevention, diagnosis, and treatment of cancer, cancer screening and cancer genetic, and risk assessment; endocrinology services; general medicine and health screening services; cardiology services; and paediatrics services. The Diagnostic & Aesthetics Business segment provides radiology and diagnostic imaging services; refractive surgery services; dental services, including general dental services, prosthodontics, orthodontics, implant dentistry, oral surgery, and gum treatment; and aesthetics medicine services consisting of facial aesthetics, body aesthetics, facial and breast fillers, IPL, lasers, Botox, microdermabrasion minimally invasive Silhouette threadlift, VASER-assisted LipoSelection, and plastic surgery. The Others segment offers business consultancy and telemedicine services. The company also offers breast related medical services; develops software/e-commerce applications for medical related services, as well as operates approximately 30 clinics. The company was incorporated in 2005 and is based in Singapore.
Research context
Singapore Medical Group Limited appears in PyInvesting’s Singapore Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- SGD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Singapore Medical Group Limited is currently in a long term downtrend where the price is trading 5.3% below its 200 day moving average.
From a valuation standpoint, the stock is 74.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Singapore Medical Group Limited's total revenue rose by 237.8% to $87M since the same quarter in the previous year.
Its net income has increased by 137.0% to $9M since the same quarter in the previous year.
Finally, its free cash flow fell by 29.9% to $5M since the same quarter in the previous year.
Based on the above factors, Singapore Medical Group Limited gets an overall score of 3/5.